Government admits problem of exorbitant pricing of drugs in SC for first time
World1 source1 country🔦 Under-reported54m ago
The government has acknowledged the issue of exorbitant drug pricing in the Supreme Court for the first time. This admission marks a significant shift in the official stance on pharmaceutical pricing disputes currently under judicial review.
The development brings increased attention to the cost of medications and the regulatory mechanisms governing pharmaceutical pricing in the country, highlighting growing scrutiny over healthcare affordability.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
Times of India (IN)Highlights the unprecedented nature of the government's admission regarding drug prices in court.
Newz